LKB1 Mutation Status is Associated with Poor Radiation Outcome in Patients with Non-Small Cell Lung Cancer

被引:0
|
作者
Sitthideatphaiboon, P. [1 ]
Cobo, A. [2 ,3 ]
Poteete, A. [2 ,3 ]
Zhang, F. [2 ,3 ]
Lui, D. [4 ]
Rinsurongkawong, W. [5 ]
Heymach, J. [6 ]
机构
[1] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Div Med Oncol, Dept Med,Fac Med, Bangkok, Thailand
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
关键词
Liver Kinase B1; Kelch-like ECH-Associated Protein 1; Radio-resistance;
D O I
10.1016/j.jtho.2018.08.1705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.03-28
引用
收藏
页码:S921 / S921
页数:1
相关论文
共 50 条
  • [41] ANALYSIS OF PTEN MUTATION STATUS IN CHINESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Su, Jian
    An, She-Juan
    Huang, Ying
    Chen, Shi-Liang
    Guo, Wei-Bang
    Chen, Zhi-Hong
    Tang, Hong-Yan
    Zhi, Xie
    Chen, Jian-Guang
    Zhang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S960 - S961
  • [42] Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose
    Inge, Landon J.
    Coon, Keith D.
    Smith, Michael A.
    Bremner, Ross M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (03): : 580 - 586
  • [43] LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro
    Xiao, Ping
    Sun, Lin-lin
    Wang, Jing
    Han, Rui-li
    Ma, Qing
    Zhong, Dian-sheng
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (09) : 1107 - 1112
  • [44] EGFR mutation status in a series of Turkish non-small cell lung cancer patients
    Calibasi-Kocal, Gizem
    Amirfallah, Arsalan
    Sever, Tolga
    Unal, Olcun Umit
    Gurel, Duygu
    Oztop, Ilhan
    Ellidokuz, Hulya
    Basbinar, Yasemin
    BIOMEDICAL REPORTS, 2020, 13 (02) : 1 - 9
  • [45] LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
    Han, Dong
    Li, Shao-Jun
    Zhu, Yan-Ting
    Liu, Lu
    Li, Man-Xiang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4033 - 4039
  • [46] Prognostic Impact of LKB1 Expression in Advanced Non-Small-Cell Lung Cancer
    Diaz-Garcia, D. A.
    Ramirez Tirado, L. A.
    Aviles-Salas, A.
    Cardona, A. F.
    Rodriguez-Rios, A.
    Barron, F.
    Arrieta, O. G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S780 - S781
  • [47] Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancer
    Jung, Soo-Jung
    Kim, Dong-Sun
    Park, Won-Jin
    Lee, Hyunsu
    Choi, In-Jang
    Park, Jae-Yong
    Lee, Jae-Ho
    ONCOLOGY LETTERS, 2017, 14 (02) : 1609 - 1614
  • [48] Rare but poor prognosis of TERT promoter mutation in non-small cell lung cancer patients
    Jung, Jung-Soo
    Kim, Dong-Sun
    Park, Won-Jin
    Lee, Hyunsu
    Choi, In-Jang
    Park, Jae-Yong
    Lee, Jae-Ho
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S29 - S30
  • [49] Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
    Grbesa, Ivana
    Pajares, Maria J.
    Martinez-Terroba, Elena
    Agorreta, Jackeline
    Mikecin, Ana-Matea
    Larrayoz, Marta
    Idoate, Miguel A.
    Gall-Troselj, Koraljka
    Pio, Ruben
    Montuenga, Luis M.
    PLOS ONE, 2015, 10 (04):
  • [50] Overexpression of Derlin-1 is Associated with Poor Prognosis in Patients with Non-small Cell Lung Cancer
    Mao, Minhua
    Zhang, Jinsong
    Jiang, Jueru
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (01): : 29 - 34